We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

19 hedge funds and large institutions have $47K invested in Coeptis Therapeutics Warrants in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding

Funds holding: 19 → 19 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

70% less capital invested

Capital invested by funds: $155K → $47K (-$108K)

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$391
2
HF
HRT Financial
New York
+$112
3
Bank of America
Bank of America
North Carolina
+$8
4
CS
Clear Street
New York
+$8
5
UBS Group
UBS Group
Switzerland
+$4

Top Sellers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
-$19K
2
Wells Fargo
Wells Fargo
California
-$6.23K
3
RCM
Radcliffe Capital Management
Pennsylvania
-$5.25K
4
AA
AQR Arbitrage
Connecticut
-$1.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
$12.8K – – –
ICM
2
Ionic Capital Management
New York
$11.7K – – –
RCM
3
Rivernorth Capital Management
Florida
$3.39K – – –
MC
4
Meteora Capital
Florida
$3.35K – – –
CL
5
CSS LLC
Illinois
$3.33K – – –
HF
6
HRT Financial
New York
$3K +$112 +2,739 +3%
Walleye Capital
7
Walleye Capital
New York
$2.46K – – –
AA
8
AQR Arbitrage
Connecticut
$1.74K -$1.3K -31,854 -41%
Walleye Trading
9
Walleye Trading
New York
$1.64K – – –
SIA
10
SkyView Investment Advisors
New Jersey
$1K – – –
WAM
11
Wolverine Asset Management
Illinois
$734 +$391 +9,555 +42%
LCM
12
Landscape Capital Management
New Jersey
$724 – – –
SM
13
Skaana Management
New York
$659 – – –
HHGC
14
Hunting Hill Global Capital
New York
$370 – – –
CS
15
Clear Street
New York
$36 +$8 +200 +14%
Bank of America
16
Bank of America
North Carolina
$4 +$8 +200 New
Wells Fargo
17
Wells Fargo
California
$2 -$6.23K -152,254 -100%
UBS Group
18
UBS Group
Switzerland
$2 +$4 +100 New
KC
19
Kepos Capital
New York
– -$19K -250,000 Closed
RCM
20
Radcliffe Capital Management
Pennsylvania
– -$5.25K -70,506 Closed

COEPW Hedge Fund Activity: Q3 2023 in Review

19 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q3 2023, worth a combined $47K — down 70% from $155K a quarter earlier.

Fund positioning in COEPW was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $391. The largest seller was Kepos Capital, exiting entirely with an estimated $19K sold.

  • 19 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $47K of Coeptis Therapeutics Warrants stock for Q3 2023, down 70% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q3 2023 and 2 closed out, a net change of 0 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q3 2023 was Wolverine Asset Management, an estimated $391 added.
  • The largest Coeptis Therapeutics Warrants seller in Q3 2023 was Kepos Capital, an estimated $19K sold.

Based on aggregated 13F filings for Q3 2023.